Parenteral Drugs (India) (NSE:PDPL) Common Stock: ₹298.16 Mil (As of Mar. 2022)


NSE:PDPL Parenteral Drugs (India) Ltd NSE:PDPL
4 GF Score
Price ₹2.90
View Full Analysis

What is Parenteral Drugs (India) Common Stock?

Parenteral Drugs (India) NSE:PDPL 4 Common Stock is ₹298.16 Mil as of Mar. 2022. GuruFocus rates NSE:PDPL with a GF Score™ of 4/100.

Parenteral Drugs (India)'s quarterly common stock declined from Sep. 2021 (₹298.16 Mil) to Dec. 2021 (₹0.00 Mil) but then increased from Dec. 2021 (₹0.00 Mil) to Mar. 2022 (₹298.16 Mil).

Parenteral Drugs (India)'s annual common stock stayed the same from Mar. 2020 (₹298.16 Mil) to Mar. 2021 (₹298.16 Mil) and stayed the same from Mar. 2021 (₹298.16 Mil) to Mar. 2022 (₹298.16 Mil).

Parenteral Drugs (India) Common Stock Historical Data

* Premium members only.

The historical data trend for Parenteral Drugs (India)'s Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) Common Stock Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 298.16 298.16 298.16 298.16 298.16

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 298.16 0.00 298.16 0.00 298.16
NSE:PDPL
4GF Score
Parenteral Drugs (India) Ltd NSE:PDPL
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parenteral Drugs (India) Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹298.16 Mil mean?
Parenteral Drugs (India) (NSE:PDPL) has a Common Stock of ₹298.16 Mil as of Mar. 2022. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Parenteral Drugs (India) and its competitors.
Is Parenteral Drugs (India)'s Common Stock too high?
Parenteral Drugs (India)'s current Common Stock is ₹298.16 Mil. Overall, Parenteral Drugs (India) has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Parenteral Drugs (India)'s Common Stock compare to ZTS and CTLT?
Parenteral Drugs (India)'s Common Stock of ₹298.16 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Parenteral Drugs (India) and its competitors. Parenteral Drugs (India)'s current Common Stock is ₹298.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parenteral Drugs (India) stock overvalued right now?
Parenteral Drugs (India) (NSE:PDPL) has a current Common Stock of ₹298.16 Mil. The current Common Stock is ₹298.16 Mil. Parenteral Drugs (India)'s overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Parenteral Drugs (India) (NSE:PDPL), the current Common Stock is ₹298.16 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Parenteral Drugs (India) Business Description

Address Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
4GF Score

Get the complete analysis for NSE:PDPL

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.90
Price